Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

As Deal To Reopen Government Reached, FDA Could Pick Up Review Pace, But Will Face Backlog

Executive Summary

On Friday, President Trump and Congress reached an agreement  to reopen the federal government for three weeks until Feb. 15, for 2019 budget negotiations. While FDA’s device center has been understaffed due to furloughs during the shutdown, a reduced team that has been processing submissions should be able to pick up the pace once sidelined reviewers return next week. But there will also be a big backlog.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel